Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitorsRenguo Guan, Rongping Guo, Min Deng et al.|International Journal of Surgery|2024Cited by 36